Variable | n = 16 |
---|---|
Age, years (range) | 5.7 (1.3–17.7) |
Sex, n (%) | |
Male | 11 (68.8) |
Female | 5 (31.3) |
Cancer type, n (%) | |
Adrenal neuroblastoma | 3 (18.8) |
Acute lymphoblastic leukemia | 2 (12.5) |
Retinoblastoma | 2 (12.5) |
Wilms’ tumor | 2 (12.5) |
Acute myeloid leukemia | 1 (6.3) |
Hodgkin’s lymphoma | 1 (6.3) |
Non-Hodgkin lymphoma | 1 (6.3) |
Medulloblastoma | 1 (6.3) |
Mediastinal neuroblastoma | 1 (6.3) |
Rhabdomyosarcoma | 1 (6.3) |
CNS tumor | 1 (6.3) |
Irradiated region, n (%) | |
Abdomen | 3 (18.8) |
Mediastinum | 3 (18.8) |
Head | 2 (12.5) |
Head and spine | 2 (12.5) |
Orbit | 2 (12.5) |
Lower extremity | 1 (6.3) |
Pelvis | 1 (6.3) |
Lung | 1 (6.3) |
Testicle | 1 (6.3) |
Thyroid–hot spot distance, cm | 14 (4–27) |
Total prescribed dose, cGy | 3600 (1350–14400) |
Scattered dose to the thyroid (TPS), cGy | |
Min | 92 (9–3780) |
Mean | 186 (12–4111) |
Max | 542 (17–4370) |
Scattered dose to the thyroid (TLD), cGy | 283 (1–6754) |
Data are expressed as n (%) or median (range). |